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Numerous bacterial strains produce surface lectins, commonly in the form of fimbriae that are filamentous 
assemblies of protein subunits. Among the best characterized of these are the type 1 (mannose specific) fim- 
brial lectins of Escherichia coli that consist almost exclusively of one class of subunit with a molecular mass 
of 17 kDa. They possess an extended combining site corresponding to a trisaccharide and preferentially 
bind carbohydrate units of oligomannose or hybrid type. Type 1 fimbriae also possess a hydrophobic region 
close to the carbohydrate-binding site, since aromatic a-mannosides inhibit strongly (up to lOOO-times more 
than methyl a-mannoside) the agglutination of yeasts by the bacteria and the adherence of the latter to pig 
ileal epithelial cells. The combining sites of type 1 fimbriae of the salmonellae and of other enteric bacteria 
are different from those of E. coli in that they are smaller and do not possess a hydrophobic region. The 
various bacterial surface lectins appear to function primarily in the initiation of infection by mediating bac- 
terial adherence to epithelial cells, e.g. in the urinary and gastrointestinal tracts. The mannose specific lectins 
also act as recognition molecules in lectinophagocytosis (i.e. phagocytosis of the bacteria in the absence of 
opsonins) by mouse, rat and human peritoneal macrophages, and human polymorphonuclear leukocytes. 
Affinity chromatography of membrane lysates from human polymorphonuclear leukocytes on immobilized 
type 1 fimbrial lectin, using methyl u-mannoside as eluent, showed that glycoproteins with apparent molecu- 
lar masses of 7&80, 100 and 150 kDa act as receptors for the bacteria. Inhibition experiments with mono- 
clonal antibodies suggest hat the glycoprotein bands of 100 and 150 kDa may be identical with the a and 
/l subunits of leukocyte complement receptors and adhesion glycoproteins involved in complement-mediated 
opsonophagocytosis. The systems described serve as a fine illustration for the biological role of lectin-carbo- 
hydrate interactions. Further studies of these systems will lead to a deeper understanding of the molecular 
basis of infectious diseases, and perhaps also to new approaches for their prevention. 
1. INTRODUCTION 
The occurrence in plant seeds of proteins that 
agglutinate erythrocytes was first noted one hun- 
dred years ago [l]. That these hemagglutinins, 
known for a long time as phytohemagglutinins or 
phytoagglutinins, are inhibited by simple sugars, 
i.e. they are sugar specific, was discovered by 
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Sumner and Howell in 1936. During the next 
decade, Boyd and Renkonen independently found 
that certain plant agglutinins are blood group 
specific (e.g. lima bean agglutinin reacts specifical- 
ly with human blood type A erythrocytes). Boyd 
[2] in 1954 proposed “that these blood antigen 
specific plant agglutinins be called l&ins, from the 
Latin fegere, to pick out or choose, intending thus 
to call attention to their specificity without begging 
the question as to their nature”. The term lectin 
was subsequently broadened to include all sugar 
specific and cell agglutinating proteins of nonim- 
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mune origin, whether from plants, animals or 
microorganisms [3,4]. 
Although scattered reports on the ability of 
bacteria to agglutinate erythrocytes appeared in 
the literature during the first half of the century, 
systematic research on the bacterial hemagglutin- 
ins started only in the 1950’s, with the work of 
Duguid in England and of Brinton in the USA 
[5-71. Duguid and his co-workers showed that 
hemagglutinating activity is a property expressed 
by many bacterial species, most commonly by 
those belonging to the family of Enterobacteria- 
ceae. They further demonstrated the existence of 
two major classes of bacterial hemagglutinin: (i) 
those that are inhibited by low concentrations of 
mannose, methyl cY-mannoside and mannan, 
which were designated as mannose sensitive (MS in 
brief); and (ii) those that are not inhibited by the 
above carbohydrates and which have been desig- 
nated as mannose resistant (or MR). We now 
know, however, that many of the hemagglutinins 
of mannose resistant strains exhibit distinct sugar 
specificities (table 1). Moreover, bacterial cultures 
often express three or four hemagglutinins, each 
with different carbohydrate specificity. 
The pioneering work of Duguid and of Brinton 
also demonstrated that the hemagglutinins de- 
scribed are nearly always associated with the 
presence on the surface of the bacteria of multiple 
submicroscopic filamentous appendages which 
have been designated as fimbriae (Latin for 
fringes) or pili (Latin for hairs). Several types of 
fimbriae, with respect o their structure and sugar 
specificity, have been identified ([7] and table 1). 
The best characterized of these are type 1 or com- 
mon fimbriae of E. co/i that are mannose specific, 
and type P fimbriae, also of E. coli, specific for 
Gah4Gal. Other examples are type S fimbriae of 
E. coli, specific for NeuAccu2-+3Gal, and type 2 
fimbriae of oral actinomyces, specific for @- 
galactosides. Purified fimbriae consist of fim- 
brillin (or pilin) subunits, the majority of which 
have a molecular mass in the range of 15-22 kDa. 
Each filament is made up of several hundred 
Table 1 
Sugar specificity of bacterial surface agglutinins” 
Saccharide Bacteria Fimbriae 
Mannose 
Galactose 
L-Fucose 
N-Acetylglucosamine 
N-Acetylgalactosamine 
Gala4Galp- 
Gap4Glc 
Gav4GlcNAc 
GlcNAqY3Gal 
NeuAccu2 -+ 3Galp3GalNAc 
Escherichia coli, Klebsiella 
pneumoniae, Pseudomonas 
aeruginosa, Salmonella spp., 
Serratia marcescens, Shigelia 
flexneri 
Escherichia coli 
Vibrio cholerae 
Escherichia colib 
Escherichia coli 
Escherichia coli 
Actinomyces naeslundii, 
Actinomyces viscosus 
Staphylococcus aprophyticus 
Streptococcus pneumoniae 
Escherichia colr’, 
Streptococcus mitis, S. 
sanguisd, Mycoplasma 
gallisepticum, Mycoplasma 
pneumoniae 
Escherichia coli 
type 1 
type G 
Wpe P 
0w 2 
type s
K99 
a For additional references and further details, see [7] 
b [81 
= [91 
d [lOI 
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subunits. Most fimbriae are very stable structures, 
being resistant to detergents and chaotropic 
agents. The purified fimbriae bind to cells contain- 
ing the complementary surface sugars, but in most 
cases they do not act as agglutinins unless they 
have been polymerized, for example by treatment 
with glutaraldehyde or anti-fimbrial antibodies. 
Strictly speaking, they do not conform to the 
definition of lectins [4], but because they are sugar 
specific and of nonimmune origin, it is convenient 
to refer to them as such. Other designations used 
in the literature for these substances are ‘adhesins’ 
or ‘agglutinins’. 
The study of the bacterial surface lectins is a fast 
developing area and a most exciting one. It is 
motivated largely by the realization of the great 
Fig. 1. Electron micrograph of type 1 fimbriated E. co&. 
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importance of bacterial adhesion in infection, and detachment from the cell surface, followed by dif- 
by the demonstration that some of these lectins ferential centrifugation or by salt precipitation. 
may act as virulence factors. Adherence of the Because of their hydrophobicity, they have a 
bacteria to host cells protects them from being strong tendency to aggregate, which may account 
swept away by the normal cleansing mechanisms for the reports that the isolated fimbriae ag- 
operating on mucosal surfaces, such as urinary glutinate yeasts or guinea pig erythrocytes in a 
flow, thereby increasing their ability to colonize mannose specific manner. The fimbrillin subunit 
the epithelia, multiply and invade the host. This of type 1 E. coli is composed of 158 amino acid 
has been most convincingly demonstrated in residues. Evidence, mainly based on genetic ex- 
animal experiments for the mannose and Gah4Gal periments, strongly suggests the presence in type 1 
specific lectins of the Enterobacteriaceae, and may fimbriae of a very small amount of an additional 
also be the case with the sialic acid specific lectins subunit, not easily detected by SDS-polyacryl- 
of several of the mycoplasma. The galactose amide gel electrophoresis, which may carry the 
specific surface lectins of the actinomyces enable carbohydrate-binding site of the fimbriae [ 14,151. 
the organisms to bind to certain streptococci and, This subunit is probably located on the distal tip of 
thus, may function in the mixed colonization of the fimbriae, in a position suitable for mediating 
teeth and other oral surfaces. the adherence of the bacteria to cells [16]. 
As well as functioning in the initiation of infec- 
tion, to the disadvantage of the host, certain of the 
bacterial surface lectins may play a beneficial role, 
by mediating the adherence of the bacteria to the 
host phagocytes. In this way they may provide the 
host with a means of eliminating the bacteria in the 
absence of opsonins, a mechanism named by us 
‘lectinophagocytosis’ (Ofek, I. and Sharon, N., in 
preparation). These varied systems provide an ex- 
cellent illustration of how lectins can mediate in- 
tercellular recognition. More importantly, there is 
good reason to believe that studies of the bacterial 
surface lectins and the identification of their recep- 
tors will lead to a clearer understanding of the 
molecular basis of infection and to the develop- 
ment of novel approaches for its prevention. 
The fimbrillin subunits of type 1 fimbriae of dif- 
ferent E. coli strains have the same molecular size 
and similar amino acid composition. Those of 
other enterobacteria, e.g. Klebsiella pneumoniae 
and Salmonella typhimurium, are different in both 
size and composition [ 131. 
3. MOLECULAR GENETICS 
In this lecture I shall focus on the properties and 
possible functions of the mannose specific surface 
lectins, in which I have been interested since the 
middle 1970’s. Further information on these and 
other bacterial ectins, including soluble ones, may 
be found in a recently published book [l I]. 
2. TYPE 1 FIMBRIAE 
Almost all strains of E. coli, as well as many 
species of other enteric bacteria, express (or have 
the genetic potential to express) type 1 fimbriae 
[ 12,131. These fimbriae are uniformly distributed 
on the bacterial cells (fig.1). Their length varies 
from 0.2 to 1 pm, their width is 7 nm, and their 
number is commonly between 100 and 400 per cell. 
They can be isolated and purified by mechanical 
The early work of Brinton [6] has shown that the 
synthesis and surface expression of type 1 fimbriae 
are coded by genes located in the bacterial chro- 
mosome. It has also been known for a long time 
that bacteria genotypically capable of producing 
the fimbriae may spontaneously shift back and 
forth from a fimbriated phase to a non-fimbriated 
one, a phenomenon known as phase variation [5]. 
In other words, the cells are either fimbriated or 
bald. This phase variation occurs at a relatively 
high frequency - approximately one/thousand 
bacteria per generation - which is several orders of 
magnitude higher than the rate of mutation. Phase 
variation should be taken into consideration in 
studies with fimbriated bacteria. Cultures rich in 
type 1 fimbriae are best obtained by growth in 
static conditions in broth, but not on agar, while 
the presence of glucose in the broth causes 
overgrowth of the non-fimbriated phenotype over 
the fimbriated type [5]. Phase variation also occurs 
in vivo. This was first postulated by us to account 
for the finding that bacteria recovered from the 
urine of patients with urinary tract infection are 
frequently non-fimbriated, although they are 
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genetically capable of producing the fimbriae [ 171. 
Direct evidence was subsequently presented by 
several groups. For example, fimbriated E. coli 
cells become non-fimbriated during growth in 
chambers implanted in the peritoneal cavities of 
mice [18]. 
Recent genetic analysis has demonstrated that 
several genes - designated fimA, fimB, etc. (or 
pilA, pilB) and closely located on the bacterial 
chromosome - are required for the expression of 
type 1 fimbriae [ 13-151. They code for proteins 
that are structural or functional subunits of the 
fimbriae, or those that control their synthesis and 
assembly. Thus, fimA codes for a protein of 19 
kDa which is the precursor of fimbrillin, fimE for 
a protein of 31 kDa which is apparently the carbo- 
hydrate-binding subunit, and fimF for a protein 
that controls fimbrial length. Formation of the 
fimbriae and expression of the carbohydrate- 
binding activity can be genetically separated: 
mutations outside the fimbrillin gene abolish the 
ability of the bacteria to bind to cells, but not the 
expression of the fimbriae. It has further been 
found that phase variation is genetically controlled 
at the transcriptional evel [19]. The phenomenon 
occurs due to the periodic inversion of a specific 
300-bp DNA segment containing the promoter for 
the fimA gene. The phase switch is controlled by 
the products of two regulatory genes, fimB and 
fimE, located upstream of fimA [20]. The fimB 
and fimE proteins direct the phase switch into the 
‘on’ and ‘off’ positions, respectively. These pro- 
teins are highly basic, implying that they control 
the phase switch through interaction at the DNA 
level. 
4. CARBOHYDRATE SPECIFICITY 
Detailed characterization of the combining site 
of the bacterial surface lectins is important not on- 
ly for gaining a better insight into the nature of the 
interaction between bacteria and cell surfaces, but 
also for the design of more effective inhibitors of 
adhesion to mucosal surfaces and thus for the 
prevention of infection. We therefore examined 
the inhibitory effect of a large number of glyco- 
sides and oligosaccharides of mannose on the ag- 
glutination of yeasts by E. co/i (fig.2), K. 
pneumoniae, Salmonella spp. and, in the case of 
E. cob, also by type 1 fimbriae isolated from this 
organism [21,22]. 
Among the compounds tested, the best inhibi- 
tors of type 1 fimbriae of E. coli are the branched 
oligosaccharides Mancu6[Mam3]Mancu6[Mana3]- 
MancvOMe and Mancu6[Mam3]MamB[Mancu2- 
Mancu3]MancrOMe, and the trisaccharide Mamr3- 
MarQ4GlcNAc (table 2). Our findings were 
recently confirmed by Neeser et al. [23], who used 
guinea pig erythrocytes instead of yeasts as in- 
dicator cells. We have also found that the disac- 
charide Mana3Man, as well as the tetrasaccharide 
Man~2Man~3Mar@4GlcNAc and the pentasac- 
charide Mancr2Mancr2Mancr3Mar@4GlcNAc, are 
poor inhibitors of yeast agglutination by E. coli. 
This had led us to postulate that the combining site 
of the type 1 fimbrial lectin corresponds to the size 
of a trisaccharide (fig.3) and that it is in the form 
of a depression or pocket on the surface of the lec- 
tin. Extended carbohydrate-binding sites have 
been described for enzymes (e.g. lysozyme), 
several ectins and antibodies. In the case of the E. 
cofi lectin, there are probably three adjacent sub- 
sites, each of which accommodates a monosac- 
charide residue. 
The presence of a hydrophobic binding region 
adjacent to the binding site of type 1 fimbriae is 
suggested by the finding that aromatic a-manno- 
sides are powerful inhibitors of the agglutination 
of yeasts by E. coli and of the adherence of the 
bacteria to guinea pig ileal epithelial cells [24] 
(table 3). In both systems, the best inhibitors were 
4-methylumbelliferyl a-mannoside and p-nitro-o- 
chlorophenyl a-mannoside (500-lOOO-times more 
inhibitory than methyl a-mannoside). 4-Methyl- 
umbelliferyl cY-mannoside was also more effective 
than methyl cu-mannoside in removing adherent E. 
coli from ileal epithelial cells. 
The strict specificity of the E. coli lectin for a- 
mannosides is manifested by the findings that: (i) 
4-methylumbelliferone is inactive even at a concen- 
tration which is well over lOO-times higher than the 
concentration of 4-methylumbelliferyl a-manno- 
side required for 50% inhibition of the E. coli lec- 
tin; and (ii) both methylumbelliferyl cr-glucoside 
and p-nitrophenyl P-mannoside are not inhibitory. 
The above results further suggest that 4-methyl- 
umbelliferyl a-mannoside and p-nitro-o-chloro- 
phenyl a-mannoside can provide a basis for the 
design of therapeutic agents that may prevent 
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Fig.2. Inhibition by mannose glycosides and oligosaccharides of yeast aggregation by E. coli 346 (025). (Data from [21].) 
adherence in vivo and infection by E. coli strains 
that express the mannose specific lectins. 
The postulated combining site of type 1 fimbriae 
is different from that of concanavalin A, a plant 
lectin with a closely related sugar specificity. The 
agglutinating activity of concanavalin A is in- 
hibited by both mannose and glucose, whereas that 
of E. coli is not inhibited by glucose; Mancu2Man 
is a considerably better inhibitor of concanavalin 
A than is methyl cu-mannoside, in contrast to what 
is found with the E. cofi lectin. 
Although all strains of E. coli examined, as well 
as K. pneumoniae, exhibited essentially the same 
pattern of specificity, this is not the case with other 
enterobacteria [22]. For example, with several 
Salmonella species examined, aromatic a-manno- 
sides, as well as the trisaccharide Mancu3Man,f34- 
GlcNAc, were weaker inhibitors than methyl 
Lu-mannoside. The combining site of different Sal- 
monella species is probably smaller than that of E. 
coli or K. pneumoniae, and is devoid of a hydro- 
phobic region. Different combining sites appear to 
be expressed by several other mannose specific 
bacterial lectins. Therefore, although classified 
under the general term mannose specific (or man- 
nose sensitive), the fimbrial lectins of different 
genera and species differ in their sugar specificity. 
Within a given genus, however, all strains tested 
exhibit the same specificity. This pattern probably 
reflects the conservation of genes which code for 
the sugar-combining sites in various genera of 
enterobacteria. 
In general, it appears that mannose specific 
bacteria preferentially bind structures found in 
short oligomannose chains (and in hybrid units, 
see below) of N-linked glycoproteins. Such struc- 
tures are common constituents of many eukaryotic 
cell surfaces [25], which accounts for the fact that 
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Table 2 
Oligomannosides are potent inhibitors of E. coli type 1 fimbrial lectin 
June 1987 
Compound Relative inhibition 
of agglutinationa 
Yeastsb Guinea pig 
erythrocytesC 
MancvMe 
/ 
MarQ4GlcNAc 
Mancu3 
Mancu6 
> Mancu6 Mancr3 
> 
MamzOMe 
Mancz3 
Mancu6 
Mancu6 
Manm3 > 
Mancu3 > 
MarQ4GlcNAc$4GlcNAc-Asn 
Mamr6 
> 
Mana 
Mancu3 
Manru2Mancu3 > 
MancuOMe 
1 1 
21 25-30 
30 
40 
30 
Mancu6 
Mana > 
Mancu6 
MancuZMancu3 > 
Man,&4GlcNA@4GlcNAc-Asn 7.5 
a Data are expressed as efficiency of inhibition of agglutination relative to methyl a-mannoside (MawMe) 
b WI 
c 1231 
SUBSITE 
BINDING 
I 
,x, 
REGION 
t-J 8:: 
Fig.3. Scheme of combining site of E. coli mannose 
specific surface lectin. 
Table 3 
Inhibition by aromatic cy-mannosides of the interaction 
of E. coli with yeasts and intestinal epithelial cell? 
Aglycon 
Methyl 
Phenyl 
p-Nitrophenyl 
p-Bromophenyl 
p-Ethylphenyl 
p-Methoxyphenyl 
p-Ethoxyphenyl 
p-Nitro-o-chlorophenyl 
p-Methylumbelliferyl 
a Data from [24] 
Relative inhibitory activity 
Agglutination Adherence to 
of yeasts epithelial 
cells 
E. co/i 025 E. coIi 0128 
1 1 
40 n.t. 
69 70 
72 n.t. 
77 150 
140 70 
154 240 
717 470 
600 1015 
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mannose specific bacteria bind to a wide variety of 
cells. Animal membrane glycolipids are unlikely to 
serve as receptors for mannose specific bacteria, 
since they are devoid of mannose residues. 
Further support for these conclusions comes 
from the measurements of the binding of mannose 
specific E. coli to mammalian cells that differ in 
the level of oligomannose units on their surfaces. 
Animal cells treated with swainsonine, an inhibitor 
of the processing of asparagine-linked oligosac- 
charide units of glycoproteins, express increased 
levels of oligomannose or hybrid type oligosac- 
charides on their surfaces, and decreased levels of 
complex oligosaccharides. Such cells bound in- 
creased numbers (1 S-2-fold) of mannose specific 
E. coli, but binding to the cells of mannose resis- 
tant E. coli was unaffected [26]. 
We have shown that mutants of baby hamster 
kidney (BHK) cells, with increased levels of N- 
linked oligomannose or hybrid units in their 
glycoproteins, bind considerably larger numbers of 
mannose specific E. coli [27] (fig.4). These cells 
were also more sensitive to agglutination by the 
bacteria than the parental wild-type cells. The best 
example is a mutant (RicRi4) that lacks the enzyme 
N-acetylglucosaminyltransferase I, which catalyses 
the first step in the conversion of oligomannose 
Fig.4. Mannose specific binding of E. coli 346 to wild- 
type and ricin resistant (Ric) baby hamster kidney (BHK) 
cells. The symbols above each bar denote the predomi- 
nant N-linked oligosaccharide expressed on the surface 
of the BHK cells: (7) Mannose; (0) N-acetylglucos- 
amine; (A) galactose; (w) sialic acid. (Data from [26].) 
units into complex ones. This mutant bound 
4-times more E. coli 346, and was agglutinated at 
a rate more than lo-times faster than the BHK 
parental cells. Preference for binding to hybrid 
units was indicated by experiments with mutants 
which express high levels of such units on their 
surface. 
5. BIOLOGICAL ROLES 
5.1. Initiation of infection 
There is now considerable evidence to support 
the idea that the bacterial surface lectins function 
in the initiation of infection [7]. In one approach 
the ability of inhibitors of adherence - either 
sugars or antibodies - to prevent infection was ex- 
amined. 
In the first study of its type, a mannose specific 
E. coli was injected into the urinary bladder of 
mice in the absence or presence of methyl cy- 
mannoside [28]. The sugar caused a significant 
decrease (by a factor of 3) in the extent of bac- 
teriuria, compared to the control group (fig.5). 
Methyl a-glucoside, which is not an inhibitor of 
the mannose specific adherence, did not affect the 
incidence of bacteriuria. Inspection under the 
microscope of stained mice bladders, injected with 
E. coli in methyl a-mannoside, revealed a con- 
siderably lower number of adherent bacteria than 
control mice injected with bacteria in saline. Ex- 
posure of methyl a-mannoside (20%) of the E. coli 
strains used in this study did not decrease their 
viability. When Proteus mirabilis was injected into 
the mice instead of E. coli, no effect on the rate of 
infection was observed with either of the sugars 
tested, in accordance with the inability of these 
sugars to inhibit the adherence of P. mirabilis to 
epithelial cells. Subsequent studies showed that 
methyl cY-mannoside caused a large decrease in in- 
fection by mannose specific K. pneumoniae in the 
bladder of rats [29] and that mannose decreased 
markedly the ability of a virulent and non-fim- 
briated strain of Shigella flexneri to cause ex- 
perimental keratoconjunctivitis in guinea pigs [30]. 
Glucose had no effect on the infectivity of either of 
these bacteria (fig.5). 
Blocking of the type 1 fimbriae by polyclonal 
antibodies (in rats) or by monoclonal antibodies 
(in mice) by active or passive immunization of the 
animals against the purified fimbriae completely 
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Fig.5. Sugar inhibitors of mannose specific bacterial surface lectins prevent infection. Sugar concentrations and source 
of data: (A) 10% [28]; (B) 5% [29]; (C) 2% [30]. (YMM, methyl a-mannoside; cuMG, methyl cu-glucoside. 
protected them from ascending urinary tract infec- 
tion by the parent E. coli strain [31,32]. A similar 
result was obtained with monoclonal antibodies 
against mannose, the sugar determinant in the 
complementary host receptor, which prevented the 
attachment of mannose sensitive E. coli to various 
eukaryotic cells. On the other hand, monoclonal 
antibodies against N-acetylgalactosamine lacked 
protective activity [32]. 
In another approach, the infectivity of pairs of 
bacterial variants or phenotypes, only one of 
which expresses the type 1 fimbrial lectin, were ex- 
amined. This approach was used in studies of 
gastrointestinal infection induced by S. typhi- 
murium in mice [33], as well as of urinary tract in- 
fection induced by K. pneumoniae in rats [29] or 
by E. coli in mice [34]. In all cases, the infectivity 
of the fimbriated phenotype was several times 
higher than that of the non-fimbriated one. 
These and other studies clearly demonstrate that 
mannose specific lectins are a key factor in the 
ability of various mannose specific bacteria to 
cause experimental infection by mediating the at- 
tachment of the bacteria to the surfaces of the 
target tissues. It is also apparent that it is possible 
to prevent infection by suitable inhibitors of 
adherence. 
In addition to the above direct role ascribed to 
type 1 fimbriae in the infectious process, they may 
also function indirectly. They mediate the binding 
of E. coli to Entamoeba histolytica and the uptake 
of the bacteria by the parasites resulting in en- 
hancement of amoebic virulence [35]. They may 
also be responsible for the association between 
salmonella and schistosoma species, which may be 
the reason for the prolonged salmonellosis in 
schistosoma-infected patients [36]. 
6. LECTINOPHAGOCYTOSIS 
6.1. Lectinophagocytosis in vitro 
Recognition and ingestion of invading patho- 
gens by phagocytic cells is of major importance in 
host defense. This process, known as phagocy- 
tosis, is a complex one and consists of several key 
steps. First, bacteria or other particulate foreign 
material must be bound to the phagocytic surface. 
This adherence step is generally mediated by 
specific receptors on the phagocyte plasma mem- 
brane that interact with complementary molecular 
components that coat the surface of the pathogen. 
Typically, these coating substances are derived 
from the immune system of the host and are called 
opsonins, and the resulting process is known as op- 
sonophagocytosis. 
Lectinophagocytosis, in contrast, results from 
the interaction of lectins on either the phagocytes 
or the bacteria, with complementary carbohy- 
drates on the apposing cells ([37]; Ofek and 
Sharon, in preparation). The most thoroughly in- 
vestigated system of lectinophagocytosis i  that in 
which the mannose specific bacteria are the target 
cells (fig.6). These bacteria bind avidly through 
their surface lectins to various types of phagocytic 
cells, such as mouse and rat peritoneal macro- 
phages and human polymorphonuclear leukocytes, 
in the absence of opsonins [38-401. Recently, we 
demonstrated similar binding of the bacteria to 
human peritoneal macrophages isolated from 
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Fig.6. Schematic representation f lectinophagocytosis 
mediated by the mannose specific surface lectins of E. 
coli. 
uremic patients undergoing peritoneal dialysis 
(Boner, G., Rodriguez-Ortega, M. and Sharon, 
N., in preparation). Binding elicits a burst of 
metabolic activity in the phagocytes, including the 
induction of chemiluminescence and of protein 
iodination. The degree of metabolic stimulation of 
phagocytic cells by type 1 fimbriated bacteria may 
be as high as that observed with bacteria coated 
with antibody [41]. Binding is frequently followed 
by ingestion and killing of the bacteria (fig.7), a se- 
quence of steps characteristic for the phagocytosis 
of opsonized bacteria. All these events are 
significantly inhibited if the bacteria and 
macrophages are mixed in the presence of mannose 
or methyl a-mannoside, sugars which minimally 
affect immune phagocytosis. Sugars such as galac- 
tose or L-fucose, that do not inhibit the lectins of 
mannose specific bacteria, have no effect on lec- 
tinophagocytosis of the bacteria. Also, bacteria 
from which the fimbriae were removed by 
ultraviolet irradiation were no longer phagocytised 
]401* 
Attachment of bacteria to macrophages via their 
Fig.7. Mannose specific recognition and killing of type 
1 fimbriated E. coli by mouse peritoneal macrophages. 
Concentration of methyl cu-mannoside @MM), 250 
mM.(Pocino, M., Sharon, N. and Ofek, I., un- 
published.) 
mannose specific lectins does not always lead to 
their ingestion. Whether the attached bacteria are 
ingested may depend on other surface properties, 
such as hydrophobicity and electric charge [42]. 
Several ines of evidence, in addition to specifici- 
ty studies of the type 1 fimbriae mentioned earlier, 
suggest that the receptors for these fimbriae on the 
phagocytic cells are mannose-containing lycopro- 
teins: (i) the same specificity pattern of inhibition 
is observed irrespective of the target cell used (e.g. 
yeasts, erythrocytes, BHK cells or phagocytic 
cells); (ii) a very good correlation was found be- 
tween the mannan-binding activity of the bacteria 
and the extent of their attachment to mouse 
peritoneal macrophages; (iii) the finding that 
pretreatment of type 1 fimbriated bacteria with 
yeast mannan inhibited their attachment o mouse 
and human phagocytes, whereas pretreatment of 
the phagocytes did not have such an effect, shows 
that the receptor for the bacterial lectin is on the 
surface of the phagocytes; (iv) since the only class 
of mannose-containing compounds in animal 
membranes are glycoproteins, the receptors for 
mannose specific bacteria must belong to this 
class. 
We recently isolated the receptors [43] by affini- 
ty chromatography on a column of immobilized 
type 1 fimbriae of a Nonidet P-40 lysate of 
polymorphonuclear leukocytes surface-labeled 
with “‘1 (fig.8). The material eluted from the col- 
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Fig.8. Affinity chromatography on immobilized fim- 
briae of total cell lysates of “‘I-surface labeled polymor- 
phonuclear leukocytes: (I) unbound fraction; (II) 
fraction eluted with 500 mM methyl a-mannoside. 
(Inset) Autoradiogram of SDS-polyacrylamide gel elec- 
trophoretogram of starting material (S) and column 
fractions. (Data from [43].) 
umn with 500 mM methyl m-mannoside (fraction 
II) comprised l-970 of the total trichloroacetic 
acid-precipitable radioactivity loaded on the col- 
umn. Analysis of this fraction, by SDS-polyacryl- 
amide gel electrophoresis and autoradiography, 
revealed a major band of molecular mass between 
70 and 80 kDa (gp70-80) and a minor one of 100 
kDa (gplO0). Upon longer exposure of the gel, a 
weak band of 150 kDa (gpl50) appeared. The lat- 
ter was the major band observed upon %con- 
canavalin A overlay of blots of fraction II isolated 
from an unlabeled lysate. Binding of concanavalin 
A was specific, as demonstrated by its complete in- 
hibition with 500 mM methyl a-mannoside. Addi- 
tional experiments with isolated membranes have 
shown that gp150, gplO0 and gp70-80 are enriched 
in the membrane fraction. The strong signal that 
gp150 gives with concanavalin A indicates that this 
glycoprotein may be highly glycosylated, or pre- 
sent in many copies on the surface of polymor- 
phonuclear leukocytes. 
Our results suggest that gpl50, gplO0 and 
gp70-80 are receptors for type 1 fimbriae on 
human polymorphonuclear leukocytes. This is 
supported by the finding that fraction II (4.4 
pg/ml) obtained from a total cell lysate inhibited 
(by 70%) yeast aggregation by E. cofi. No inhibi- 
tion of yeast aggregation was observed with the 
whole cell lysate at a concentration of up to 80/1g 
protein/ml. Preliminary studies with monoclonal 
antibodies, performed by Morella Rodriguez- 
Ortega in our laboratory, suggest that gpl50 and 
gplO0 may be identical with the CY and p subunits 
of leukocyte complement receptors and adhesion 
glycoproteins involved in complement-mediated 
opsonophagocytosis [44]. 
6.2. Lectinophagocytosis in vivo 
Although the occurrence of lectinophagocytosis 
mediated by bacterial surface lectins has been 
established unequivocally in vitro, little is known 
about its occurrence in vivo. Most of the evidence 
available is indirect. One line of evidence comes 
from studies with Tamm-Horsfall glycoprotein, 
the most abundant protein in normal human urine. 
This glycoprotein contains N-linked oligomannose 
units and it is not surprising that it binds to type 
1 fimbriated E. coli as well as to the isolated fim- 
briae and that this binding is inhibited by methyl LY- 
mannoside [45,46]. Bacteria coated with the 
glycoprotein were markedly less susceptible to 
mannose specific lectinophagocytosis than un- 
coated ones. Serum (opsonin) mediated phago- 
cytis, on the other hand, was not affected by the 
glycoprotein. It was suggested that these observa- 
tions may partially explain the virulence of E. coli 
in the bladder, where serum activity is low and 
Tamm-Horsfall glycoprotein is abundant. 
Further indirect evidence that mannose specific 
lectinophagocytosis may take place in vivo was ob- 
tained in experimental infection with mixed pheno- 
types, one of which expressed the mannose specific 
lectin (fim+) and the other did not (fim-). Orak 
[47] or intravesical [48] infection of mice with a 
mixture of fim+ and fim- phenotypes of E. coli 
showed predominance of the fim+ phenotype in 
the gut or bladder, and of fim- in the kidney or 
peritoneal cavity, respectively. Intravesical infec- 
tion of mice with a similar mixture of fim+ and 
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fim- phenotypes of K. pneumoniae revealed that 
the predominant phenotype in the bladder 7 days 
after infection was fim+ while that in the kidney 
was fim- [49]. These results were interpreted as be- 
ing due to selective survival of the fim+ phenotype 
on mucosal surfaces since it is capable of binding 
to epithelial cells, and selective survival of the fim- 
phenotype in deep tissues (e.g. kidney or peritoneal 
cavity) where the fim+ phenotype is eliminated by 
macrophages and/or polymorphonuclear leuko- 
cytes .
7. CONCLUDING REMARKS 
In this lecture, I have drawn heavily on informa- 
tion obtained from studies of the mannose specific 
type 1 fimbriae to illustrate the fundamental role 
that lectin-carbohydrate interactions play in cell- 
cell interactions, as well as in microbial 
pathogenicity. On the one hand, these lectins in- 
crease the virulence of the bacteria by enhancing 
bacterial adherence to epithelial cells and, on the 
other, they decrease virulence by enhancing 
phagocytosis. Much of what has been learned in 
this context about type 1 fimbriae is true for other 
bacterial surface lectins as well, although certain 
differences are also apparent. Thus, the Galu4Gal 
specific (type P) fimbriae consist of a variety of 
protein subunits, only one of which carries the 
carbohydrate-binding site, and their expression is 
controlled by multiple genes [50-521. These fim- 
briae bind to glycolipids of the globo series [53,54], 
and in this respect differ from type 1 fimbriae that 
bind to mannose-containing lycoproteins. How- 
ever, experimental infection by both types of 
bacteria can be blocked by inhibitory sugars as well 
as by anti-fimbrial antibodies. Although type P 
fimbriated E. coli bind poorly to human polymor- 
phonuclear leukocytes, since these cells are defi- 
cient in the appropriate receptors, binding is 
markedly increased if the cells are first coated with 
globotetraosylceramide (GalNA@3Gala4Gal,84- 
Glc@Cer) and binding of the bacteria to the coated 
cells results in metabolic activation [55]. Thus, 
type P fimbriated E. coli are susceptible to lectino- 
phagocytosis, as are the type 1 fimbriated bacteria. 
Lectinophagocytosis has recently been shown to be 
mediated also by type 2 fimbriae specific for ,8- 
galactosides that are expressed by certain ac- 
tinomyces species [56]. 
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It is to be expected that in the near future much 
more will be learned about the bacterial lectins 
described in this article and many others will 
probably be isolated and characterized. A detailed 
knowledge of the combining sites of these lectins 
and their receptors should lead to the design of po- 
tent inhibitors of adherence, which will hopefully 
be suitable for testing in humans. We shall also 
gain a better understanding of lectinophago- 
cytosis, and of its role in natural infection. The day 
may come when inhibitors of lectin-mediated 
adherence will be used clinically to prevent col- 
onization before the bacteria have had the chance 
to overwhelm the host. 
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